左主冠状动脉疾病用心跳手术治疗:10年单一中心结果
Tomasz K Urbanowicz1, Michał Michalak2, Anna Olasińska-Wiśniewska1
1Cardiac Surgery and Transplantology Department, Poznan University of Medical Sciences, Poznan, Poland.
概括
脱冠状动脉旁路移植 (CABG) 是左侧主要疾病的安全选择,显示与多血管疾病相似的存活率. 女性性别和糖尿病是OPCAB手术后死亡的风险因素.
科学领域:
- 心血管外科心血管外科
- 干预心脏病学 干预心脏病学
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 左主冠状动脉疾病是一种可通过皮肤或手术方法治疗的严重疾病.
- 脱冠状动脉旁路移植 (OPCAB) 是一种手术选择,尽管它的利用率已经下降.
研究的目的:
- 为了比较接受OPCAB治疗左主血管疾病的患者与多血管疾病的患者之间的10年生存率.
- 在接受OPCAB手术的患者中识别死亡风险因素.
主要方法:
- 对159名患者 (32%左主,68%多血管疾病) 的回顾性分析.
- 利用长期死亡风险和卡普兰-梅尔生存曲线的回归分析.
- 在手术后使用过境时间绕道测量.
主要成果:
- 在接受OPCAB治疗的左主和多血管疾病患者之间,10年死亡率没有显著差异 (HR = 0.93).
- 女性性别 (HR = 1.08) 和糖尿病 (HR = 6.33) 被确定为10年死亡率的重要风险因素.
- 51名患有左主疾病的患者和108名患有多血管疾病的患者进行了手术.
结论:
- 与多血管疾病相比,左主疾病的离手术是一种安全有效的技术,具有有利的长期结果.
- 女性性别和糖尿病是影响OPCAB手术后长期死亡率的潜在危险因素.
相关概念视频
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


